Safety Aspects of Iron in Food
- 1 June 2001
- journal article
- review article
- Published by S. Karger AG in Annals of Nutrition and Metabolism
- Vol. 45 (3) , 91-101
- https://doi.org/10.1159/000046713
Abstract
During the last decades efforts regarding dietary iron supply focused mostly on the prevention of deficiencies, especially during growth and pregnancy. Correspondingly, homeostatic mechanisms increase intestinal iron absorption in iron deficiency, but its downregulation at high intake levels seems insufficient to prevent accumulation of high iron stores at high intake. There is no regulated iron excretion in overload. Excess of pharmaceutical iron may cause toxicity and therapeutic doses may cause gastrointestinal side effects. Chronic iron excess, e.g. in primary and secondary hemochromatosis, may lead to hepatic fibrosis, diabetes mellitus and cardiac failure. Chronic intake of 50–100 mg Fe/day of highly bioavailable iron with home-brewed beer in sub-Saharan Africans lead to cirrhosis and diabetes. Applying a safety factor of 2 would lead to an upper safe level of 25–50 mg Fe/day for this endpoint of conventional iron toxicity. However, beyond this kind of damage iron is known to catalyze the generation of hydroxyl radicals from superoxide anions and to increase oxidative stress which, in turn, increases free iron concentration. This self-amplifying process may cause damage to lipid membranes and proteins, which relates radical generation and organ damage after ischemia-reperfusion events to available free iron in clinical and experimental settings. Correspondingly, epidemiological studies as well as observations in heterozygotes for hereditary hemochromatosis suggest that the risk of atherosclerosis and acute myocardial infarction is related to body iron stores, though there is conflicting epidemiological evidence as well. The most recent and best controlled studies, however, support the hypothesis that iron stores are related to cardiovascular risk. Iron-amplified oxidative stress may also increase DNA damage, oxidative activation of precancerogens and support tumor cell growth. This is supported by experimental, clinical and epidemiological observations. Due to these mechanisms high iron stores may present a health hazard. Though this has not been finally proven, available evidence strongly recommends not to increase iron intake beyond physiological requirements. To avoid iron deficiency symptoms, on the other hand, care must be taken to meet recommended daily intake.Keywords
This publication has 12 references indexed in Scilit:
- A Novel Duodenal Iron-Regulated Transporter, IREG1, Implicated in the Basolateral Transfer of Iron to the CirculationMolecular Cell, 2000
- Gastrointestinal function, divalent metal transporter-1 expressionand intestinal iron absorptionPflügers Archiv - European Journal of Physiology, 2000
- Transition Metal Chelators Reduce Directly Measured Myocardial Free Radical Production During ReperfusionJournal of Cardiovascular Pharmacology, 1998
- Clinical and Biochemical Abnormalities in People Heterozygous for HemochromatosisNew England Journal of Medicine, 1996
- Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress.Proceedings of the National Academy of Sciences, 1996
- Desferal Attenuates TNF Release Following Hepatic Ischemia/ReperfusionJournal of Surgical Research, 1994
- Body Iron Stores and the Risk of Coronary Heart DiseaseNew England Journal of Medicine, 1994
- Regulating the fate of mRNA: The control of cellular iron metabolismCell, 1993
- Free radicals and the etiology of colon cancerFree Radical Biology & Medicine, 1990
- Iron DeficiencyAnnual Review of Nutrition, 1990